Phase 2 N=652 STARS (Smoking Treatment And Remote Sampling) Study
Smoking · Smoking Cessation · Tobacco Smoking
Primary: Smoking Cessation — 16.7; 8.1; 9.9 Percent
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=30 Peer-Led Diet and Exercise Intervention
Physical Activity · Peer Leaders · Diet Quality
Primary: Change in Cardiovascular Endurance — 20 yards — p=<0.05
Phase 2 N=622 Single or Repeat Dose of G03-52-01 in Adult Subjects
Healthy · Botulinum Toxin
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 61; 61; 61; 56 Participants
Phase 2 N=82 Safety and Efficacy of RHH646 for Knee Osteoarthritis
Osteoarthritis, Knee
Primary: Change From Baseline in Cartilage Volume in the Index Region of the Target Knee by MRI — 94.6; 9.3 µL — p=0.0575
N/A N=987 Reducing Pesticide Exposures in Child Care Centers
Children, Only · Risk Reduction · Environmental Exposure
Primary: Decrease in Child Care Center Pesticides — 1.95; 1.87; 0.59; 0.53 log10(ng/g) — p=<0.05
Phase 4 N=767 GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
Immunization · Efficacy · Human Papilloma Virus
Primary: Short-term Human Papillomavirus (HPV) Type-specific Antibody Response for Type HPV-6 — 99.25; 100.00; 100.00; 100.00 % of participants with seroconversion
N/A N=82 Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
Oral Contraceptive
Primary: Breast Cell Proliferation Levels Between the Three Oral Contraceptive Groups — 8.5; 11.9; 7.5 Percent of cells staining for Ki67
N/A N=21 Evaluation of Vision-Guided Shared Control for Assistive Robotics Manipulators
Spinal Cord Injury/Disorder
Primary: Task Completion Time — 333.7; 604.7; 748.5; 1128.9 seconds
Phase 2 N=40 Visual Acoustic Biofeedback for RSE Via Telepractice
Speech Sound Disorder
Primary: Rhotic Accuracy (/r/) — 30.55; 28.60; 9.54; -.78 mean difference in percent correct
N/A N=14 Agonist-Antagonist Myoneural Interface for Functional Limb Restoration After Transtibial Amputation
Amputation
Primary: Stability of Joint Position Control in Free Space — 4; 3.1 Distinct synergy activations
N/A N=30 Trima Non-DEHP Leukoreduced Red Blood Cell In Vivo Recovery Study
Device Validation of In-vivo Performance
Primary: Number of Participants With Success of RBCs in Vivo Recovery After 42-day Storage (Single-label Method) — 24 Participants
N/A N=3,923 Effectiveness and Implementation of eScreening in Post 9/11 Transition Programs
Depression · Stress Disorders, Post-Traumatic · Suicide
Primary: Compare Rate of PTSD Screening During eScreening Implementation and Sustainment vs. Screening as Usual/Pre-implementation — 724; 1408; 893 Participants — p=<.001
N/A N=237 MAKO Total Knee Artroplasty
Osteoarthritis, Knee
Primary: Early Recovery — 3.6; 4.2 score on a scale
N/A N=178 Patient Priorities Care Among Persons Living With Mild Cognitive Impairment and Dementia
Dementia · Mild Cognitive Impairment
Primary: Documentation of PPC Discussion — 72; 106 Participants
N/A N=132 Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota in Sarcopenia Elderly
Sarcopenia · Inflammation · Aging
Primary: Impact of LCS on the Change of Gut Microbiota — 0.023577513; 0.248239465; 0.003810442; 0.10325558 % of total Bacteria — p=<0.05